FDA To Weigh HPV Shot For Women Up to 45 -- Gardasil, Used For Ages 9-26, Blocks Virus That Can Cause Cervical Cancer

WASHINGTON - The U.S. Food and Drug Administration will consider whether to expand use of a vaccine intended to prevent cervical cancer to women aged 27 to 45, the vaccine maker said Wednesday.

Gardasil, made by Merck & Co., currently is approved for use in girls and women aged 9 through 26 to block four types of human papilloma virus, which can cause cervical cancer and genital warts.

A decision is expected by mid-year.

Read full story

More on This

FDA Denies Luviva Cervical Screening Device: Editorial

Cervical Cancer May Be Possible Even After Hysterectomy

3 Ways You Can Reduce The Risk For Cervical Cancer

Cervical Cancer is Deadlier Than We Thought

Tags:

• Cervical Cancer